COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Johannes Gutenberg University Mainz · University Medical Center of the Johannes Gutenberg University Mainz · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,040
total citations
- FWCI
- 41.98
- Percentile
- 100%
- References
- 39
Citations per year
Authors
42- UŞUğur ŞahinCorresponding
Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, BioNTech (Germany), Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- AMAlexander Muik
BioNTech (Germany)
- EDEvelyna Derhovanessian
BioNTech (Germany)
- IVIsabel Vogler
BioNTech (Germany)
- LMLena M. Kranz
BioNTech (Germany)
Topics & keywords
Topics
Keywords
- Coronavirus disease 2019 (COVID-19)
- Virology
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- 2019-20 coronavirus outbreak
- Antibody
- Coronavirus Infections
- Betacoronavirus
- Antibody response
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.